Vor Ort
Merkzettel Warenkorb
  • Produktbild: Advances in Research on Neurodegeneration
  • Produktbild: Advances in Research on Neurodegeneration
Band 49

Advances in Research on Neurodegeneration 3 & 4

Aus der Reihe Journal of Neural Transmission. Supplementa

49,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

22.07.1997

Herausgeber

Y. Mizuno + weitere

Verlag

Springer Wien

Seitenzahl

280

Maße (L/B/H)

27,9/21/1,7 cm

Gewicht

820 g

Auflage

Softcover reprint of the original 1st ed. 1997

Sprache

Englisch

ISBN

978-3-211-82934-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

22.07.1997

Herausgeber

Verlag

Springer Wien

Seitenzahl

280

Maße (L/B/H)

27,9/21/1,7 cm

Gewicht

820 g

Auflage

Softcover reprint of the original 1st ed. 1997

Sprache

Englisch

ISBN

978-3-211-82934-9

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Advances in Research on Neurodegeneration
  • Produktbild: Advances in Research on Neurodegeneration
  • Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques.- Models of Alzheimer’s disease: cellular and molecular aspects.- The relationship of Alzheimer-type pathology to dementia in Parkinson’s disease.- Models to study the role of neurotrophic factors in neurodegeneration.- Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100?.- Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.- Nigrostriatal neuronal death in Parkinson’s disease — a passive or an active genetically-controlled process?.- Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer’s disease.- Cop 1 as a candidate drug for multiple sclerosis.- Possible role of the cholinergic system and disease models.- Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites.- Role of interferons in demyelinating disease.- Role of interferons in demyelinating diseases.- Mechanism of amyloid ? protein induced neuronal cell death: current concepts and future perspectives.- From prion diseases to Alzheimer’s disease.- A phosphorylation cascade in the basal ganglia of the mammalian brain: regulation by the D-1 dopamine receptor. A mathematical model of known biochemical reactions.- Molecular heterogeneity of neurotransporters: implications for neurodegeneration.- Central nervous system cytokines and their relevance for neurotoxicity and apoptosis.- Genetics of multiple sclerosis — how could disease-associated HLA-types contribute to pathogenesis?.- Modulation of control mechanisms of dopamine-induced apoptosis — a future approach to the treatment of Parkinson’s disease?.- GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson’s disease.- MRI as a method to reveal in-vivo pathology in MS.- Familial amyotrophic lateral sclerosis.- Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias.- Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.- Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex (DDPAC) is a non-Alzheimer’s frontotemporal dementia.